Esophageal Cancer Clinical Trial

Exercise Prehabilitation for Locoregional Esophageal Cancer

Summary

The purpose of the study is to examine the feasibility and acceptability of exercise "prehabilitation" for patients preparing for esophageal cancer resection (removal).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Biopsy-proven locoregional esophageal cancer (LEC)
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Treatment plan including neoadjuvant chemoradiation therapy and surgical resection
Ability to read and speak English

Exclusion Criteria:

Regular engagement in resistance training (2x/week targeting all major muscle groups)
Screen failure for exercise safety based on PAR-Q
Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
Recent fracture or acute musculoskeletal injury that precludes ability to participate in resistance training safely
Numeric pain rating scale of 7 or more out of 10
Myopathic or rheumatologic disease that impacts physical function

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

20

Study ID:

NCT06430346

Recruitment Status:

Recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Moffitt Cancer Center
Tampa Florida, 33612, United States More Info
Nathan Parker, PhD
Contact
813-745-0527
[email protected]
Nathan Parker, PhD
Principal Investigator
Jose Pimiento, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

20

Study ID:

NCT06430346

Recruitment Status:

Recruiting

Sponsor:


H. Lee Moffitt Cancer Center and Research Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.